Page 564 - Read Online

Maurina et al. Mini-invasive Surg 2021;5:53 https://dx.doi.org/10.20517/2574-1225.2021.88 Page 11 of 13

However, some issues remain debatable such as appropriate duration of post procedural antithrombotic
therapy, differences between devices, or complication management.

DECLARATIONS
Authors’ contributions
Conception and drafting of the manuscript: Maurina M, Villaschi A, Pivato CA
Supervised and provided technical and material support: Mangieri A, Chiarito M, Regazzoli D, Fazzari F,
Bertoldi L, Briani M
Revision of the manuscript for important intellectual content: Regazzoli D, Reimers B, Pagnotta P

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent for participation
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Pritchett EL. Management of atrial fibrillation. N Engl J Med 1992;326:1264-71. DOI PubMed
2. Corley SD, Epstein AE, DiMarco JP, et al; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the
Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13. DOI PubMed
3. Nielsen-Kudsk JE, Korsholm K, Damgaard D, et al. Clinical outcomes associated with left atrial appendage occlusion versus direct
oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv 2021;14:69-78. DOI PubMed
4. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation.
Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-12. DOI PubMed
5. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg
1996;61:755-9. DOI PubMed
6. Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 2013;35:312-9. DOI PubMed
PMC
7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in
atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72. DOI
PubMed
8. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of
major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100. DOI PubMed
9. Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of
atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for
the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special
contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498. DOI PubMed
10. January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice
Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol
2014;64:e1-76. DOI PubMed
11. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the